Addex Therapeutics Ltd (SWX:ADXN)
Switzerland · Delayed Price · Currency is CHF 0.0400
+0.0014 (3.63%)
Apr 1, 2026, 5:30 PM CET
Addex Therapeutics Market Cap
Addex Therapeutics has a market cap or net worth of 4.66 million as of April 1, 2026. Its market cap has decreased by -15.32% in one year.
Market Cap
4.66M
Enterprise Value
2.51M
Revenue
158.54K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
Market Cap Chart
Since May 22, 2007, Addex Therapeutics's market cap has decreased from 398.65M to 4.66M, a decrease of -98.83%. That is a compound annual growth rate of -21.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 4.66M | -27.80% |
| Dec 30, 2025 | 6.46M | 14.83% |
| Dec 30, 2024 | 5.62M | -9.01% |
| Dec 29, 2023 | 6.18M | -40.48% |
| Dec 30, 2022 | 10.39M | -73.65% |
| Dec 30, 2021 | 39.42M | -25.96% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Idorsia | 835.00M |
| Basilea Pharmaceutica AG | 646.54M |
| Newron Pharmaceuticals | 308.17M |
| Santhera Pharmaceuticals Holding AG | 211.40M |
| BioVersys AG | 175.44M |
| Molecular Partners AG | 121.40M |
| Xlife Sciences AG | 118.24M |
| EvoNext Holdings | 5.91M |